From: Effect of liberal glucose control on critically ill patients: a systematic review and meta-analysis
Subgroup | Studies | WMD (95% CI), P | I2,PHeterogeneity | Pregression |
---|---|---|---|---|
All studies | 6 | 0.34(-0.32, 1.01),0.309 | 81.2%,<0.001 | Â |
Control group target blood glucose | Â | Â | Â | 0.191 |
80–110 mg/dl | 3 | 0.90(-0.17, 1.97),0.099 | 86.1%,0.001 |  |
108–180 mg/dl | 3 | -0.14 (-1.19, 0.91)0.0.797 | 80.8%,0.005 |  |
Diabetes | Â | Â | Â | 0.191 |
Partial diabetic | 3 | 0.90(-0.17, 1.97),0.099 | 86.1%,0.001 | Â |
Diabetic | 3 | -0.14 (-1.19, 0.91)0.0.797 | 80.8%,0.005 | Â |
Study type | Â | Â | Â | 0.889 |
RCT | 4 | 0.42(-0.63, 1.46),0.433 | 88.1%<0.001 | Â |
Non-RCT | 2 | 0.44 (-0.08, 0.96),0.099 | 9.3%,0.294 | Â |